Product
Mineral Trioxide Aggregate
Aliases
MTA
4 clinical trials
6 indications
Indication
Indirect Pulp CappingIndication
PulpotomyIndication
Vital Pulp TherapyIndication
Dental Caries in ChildrenIndication
PulpitisIndication
Dentin BridgeClinical trial
Clinical and Radiographic Success of Mineral Trioxide Aggregate (MTA) vs Septodont Biodentine in Primary Molars in Pulpotomy and Indirect Pulp Cap TreatmentsStatus: Recruiting, Estimated PCD: 2025-01-01
Clinical trial
Evaluation of MTA Pulpotomy, Biodentine Pulpotomy, and Glass Ionomer Indirect Pulp Treatment in Primary TeethStatus: Active (not recruiting), Estimated PCD: 2025-02-01
Clinical trial
Comparative Evaluation of Melatonin Versus Mineral Trioxide Aggregate on Vital Pulp Therapy in Young Permanent First Molars: An in Vivo StudyStatus: Recruiting, Estimated PCD: 2024-05-20
Clinical trial
Clinical, Radiographic and Tomographic Evaluation of Apexogenesis With Human Treated Dentin Matrix in Young Permanent MolarsStatus: Completed, Estimated PCD: 2022-07-18